MEIRU
Lilongwe, Malawi
NCT Number: NCT03422185
Cross-sectional survey of all adults residing in two defined geographical regions in urban Lilongwe and rural Karonga District. Participants were interviewed, had anthropometric measures taken, and had fasting blood specimens taken.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lilongwe, Malawi
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention
Time frame: By end of 2018
Prevalence of hypertension (BP <140/90 or self-report of antihypertensive use), diabetes (fasting blood glucose >7.0 or self-report history of diabetes), and hyperlipidaemia
Time frame: By end of 2020
Description of prevalence of known risk factors of hypertension, diabetes, and hyperlipidaemia.
Dietary salt intake is estimated both by how long a defined quantity of salt is reported to last in a household on average, and from spot urine sodium specimens.
Time frame: By end of 2020
Description of HIV infection and its therapy in relationship to hypertension, diabetes and hyperlipidaemia
Malawi Epidemiology and Intervention Research Unit
Other
Understanding Local Determinants of Cardiovascular Disease and Diabetes to Inform Novel Interventional Strategies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04492384
Body Weight, CKD
Moscow, Russia
View Trial DetailsNCT03739034
Body Weight, Cardiovascular Diseases
Athens, Ohio, United States
View Trial DetailsNCT03677609
Body Weight, Cardiovascular Diseases
Stanford, California, United States
View Trial DetailsNCT03543644
Body Weight, Cardiovascular Diseases
Toronto, Ontario, Canada
View Trial Details